SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (658)4/18/1997 1:08:00 PM
From: William Presti   of 1172
 
Ouch! $1200? I'd rather spend that on additional shares of CMTR.

Just a thought, but if you read back over 10-k reports, etc. you will find that the company is working on future tests in the category of infectious diseases. Any guesses as to what they might be working on? How about a test for TB? Hope so. There is a huge global market rapid TB testing. I'd ask Ed C, but I don't think he could tell us even if they were.

About the company's burn rate. What has been burned is burned. It's history and probably no longer a good indication of future burn rates. Whatever it was in the past, .5 mill a quarter or month, was before sales of Cholestrak picked up, before ColoCARE was intoduced and before Astra Merck started taking shipments of Hp Chek (which I think they have or are about to). So, who knows what the burn rate of this and future quarters will be? Bet it's a slow burn or better yet...let's look for a no burn. Jeeza, don't forget to bring your matches to the launch pad!

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext